Zeljko Krznaric
Overview
Explore the profile of Zeljko Krznaric including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
3723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Alexdottir M, Pehrsson M, Domislovic V, Godskesen L, Krag A, Kjeldsen J, et al.
Sci Rep
. 2024 Jan;
14(1):1641.
PMID: 38238446
Neutrophils play a significant role in sustaining chronic inflammation in Inflammatory Bowel Disease. The intestinal basement membrane acts as a barrier for immunological homeostasis, where the α3 and α4 chains...
12.
Pehrsson M, Domislovic V, Alexdottir M, Brinar M, Karsdal M, Barisic A, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202027
Chronic inflammation in inflammatory bowel disease (IBD) triggers significant extracellular matrix remodeling, including elastin remodeling, leading to severe clinical complications. Novel methods to assess intestinal tissue destruction may act as...
13.
Arvanitakis M, Ockenga J, Bezmarevic M, Gianotti L, Krznaric Z, Lobo D, et al.
Clin Nutr
. 2024 Jan;
43(2):395-412.
PMID: 38169174
Both acute and chronic pancreatitis are frequent diseases of the pancreas, which, despite being of benign nature, are related to a significant risk of malnutrition and may require nutritional support....
14.
Domislovic V, Krznaric Z, Heinrich H
United European Gastroenterol J
. 2023 Oct;
11(9):907-910.
PMID: 37861391
No abstract available.
15.
Pironi L, Cuerda C, Jeppesen P, Joly F, Jonkers C, Krznaric Z, et al.
Clin Nutr
. 2023 Aug;
42(10):1940-2021.
PMID: 37639741
Background & Aims: In 2016, ESPEN published the guideline for Chronic Intestinal Failure (CIF) in adults. An updated version of ESPEN guidelines on CIF due to benign disease in adults...
16.
Resal T, Bacsur P, Keresztes C, Balint A, Bor R, Fabian A, et al.
Inflamm Bowel Dis
. 2023 Aug;
30(5):768-779.
PMID: 37542737
Background And Aims: Tofacitinib (TFB) appears to be effective in the treatment of ulcerative colitis (UC); however, available real-world studies are limited by cohort size. TFB could be an option...
17.
COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure
Pironi L, Jezerski D, Sobocki J, Lal S, Vanuytsel T, Theilla M, et al.
Clin Nutr ESPEN
. 2023 May;
55:212-220.
PMID: 37202049
Background And Aims: To investigate the incidence and the severity of COVID-19 infection in patients enrolled in the database for home parenteral nutrition (HPN) for chronic intestinal failure (CIF) of...
18.
Fistrek Prlic M, Jelakovic M, Brinar M, Grgic D, Romic I, Marusic Z, et al.
Front Med (Lausanne)
. 2023 May;
10:1097469.
PMID: 37181355
Chronic kidney disease (CKD) is a very common chronic non-communicable disease. Phosphate and calcium metabolism disorders are one of the most common features of CKD. Sevelamer carbonate is the most...
19.
Arends J, Muscaritoli M, Anker S, Audisio R, Barazzoni R, Bosnjak S, et al.
Crit Rev Oncol Hematol
. 2023 Mar;
185:103965.
PMID: 36931616
Cachexia is a life-threatening disorder affecting an estimated 50-80% of cancer patients. The loss of skeletal muscle mass in patients with cachexia is associated with an increased risk of anticancer...
20.
Burisch J, Zhao M, Odes S, De Cruz P, Vermeire S, Bernstein C, et al.
Lancet Gastroenterol Hepatol
. 2023 Mar;
8(5):458-492.
PMID: 36871566
The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease and...